Frazier Healthcare Partners Adds Experienced Business Leader Chris Peetz to Life Sciences Team
May 30 2017 - 5:00AM
Business Wire
Frazier Healthcare Partners announced today that Chris Peetz has
joined the Life Sciences team as an Entrepreneur-in-Residence
(EIR). Most recently, Mr. Peetz served as Chief Financial Officer
and Head of Corporate Development at Frazier portfolio company
Tobira Therapeutics, a leading developer of therapeutics to treat
non-alcoholic steatohepatitis (NASH). While at Tobira, Mr. Peetz
led the company’s efforts to become a public company through a
reverse merger, expand its pipeline through partnerships and
in-licensing, and sell the company to Allergan for total
consideration of up to $1.7 billion. Prior to Tobira, Mr.
Peetz held business leadership roles at Jennerex Biotherapeutics,
Onyx Pharmaceuticals and Abgenix.
As an EIR with Frazier, Mr. Peetz will focus on identifying and
in-licensing assets into a newly formed search company, Flashlight
Therapeutics. Mr. Peetz serves as the CEO of Flashlight, which is
broadly focused on oncology, liver diseases and NASH, and related
areas.
“Chris played an instrumental role in the success of Tobira, and
he brings unique partnering and financing insights to our team
having been involved in growing companies resulting in over $15
billion in corporate transactions,” said Patrick Heron, Managing
General Partner with the Frazier Life Sciences team. “He has deep
experience in areas ranging from oncolytic viruses to the leading
edge of NASH combination therapies, and we look forward to working
with him to build a new company around in-licensed assets.”
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading
provider of growth and venture capital to healthcare companies.
With nearly $3.0 billion total capital raised, Frazier has invested
in over 170 companies, with investment types ranging from company
creation and venture capital to buyouts of profitable lower-middle
market companies. The firm’s Growth Buyout team invests in
healthcare and pharmaceutical services, medical products and
related sectors. The Life Sciences team invests in therapeutics and
related areas that are addressing unmet medical needs through
innovation. Frazier has offices in Seattle, WA and Menlo Park, CA,
and invests broadly across the US, Canada, and Europe.
For more information about Frazier Healthcare Partners, visit
the company’s website at http://www.frazierhealthcare.com.
About Flashlight Therapeutics
Headquartered in Menlo Park, Calif., Flashlight Therapeutics is
a Frazier-founded search company focused on in-licensing and
developing therapeutics.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170530005216/en/
Frazier Healthcare PartnersLiz Park,
650-319-1831liz.park@frazierhealthcare.com